SEARCH

SEARCH BY CITATION

References

  • BENTLEY, J.C., BOURSON, A., BOESS, F.G., FONE, K.C., MARSDEN, C.A., PETIT, N. & SLEIGHT, A.J. (1999). Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats. Br. J. Pharmacol., 126, 15371542.
  • BENTLEY, J.C., MARSDEN, C.A., SLEIGHT, A.J. & FONE, K.C.F. (1997). 5-HT6 antisense oligonucleotide i.c.v. affects rat performance in the water maze and feeding. British Association for Psychopharmacology Meeting, Cambridge, 13–17th July 1997, P255.
  • BOESS, F.G., MONSMA, F.J., CAROLO, C., MEYER, V., RUDLER, A., ZWINGELSTEIN, C. & SLEIGHT, A.J. (1997). Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells. Neuropharmacol., 36, 713720.
  • BOURSON, A., BOESS, F.G., BOS, M. & SLEIGHT, A.J. (1998). Involvement of 5-HT6 receptors in nigro-striatal function in rodents. Br. J. Pharmacol., 125, 15621566.
  • BOURSON, A., BORRONI, E., AUSTIN, R.H., MONSMA, F.J. & SLEIGHT, A.J. (1995). Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides. J. Pharmacol. Exp. Ther., 274, 173180.
  • BOWEN, W.P. & JERMAN, J.C. (1995). Nonlinear regression using spreadsheets. Trends in Pharmacol. Sci., 16, 413417.
  • BROMIDGE, S.M., BROWN, A.M., CLARKE, S.E., DODGSON, K., GAGER, T, GRASSAM, H.L., JEFFREY, P.M., JOINER, G.F., KING, F.D., MIDDLEMISS, D.N., MOSS, S.F., NEWMAN, H., RILEY, G., ROUTLEDGE, C. & WYMAN, P. (1999). 5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): A Potent, Selective, and Orally Bioavailable 5-ht6 Receptor Antagonist. J. Med. Chem., 42, 202205.
  • CHENG, Y.C. & PRUSSOF, W.H. (1973). Relationship between inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol., 92, 881894.
  • FLETCHER, A., FORSTER, E.A., BILL, D.J., BROWN, G., CLIFFE, I.A., HARTLEY, J.E., JONES, D.E., MCLENACHAN, A., STANHOPE, K.J., CRITCHLEY, D.J., CHILDS, K.J., MIDDLEFELL, V.C., LANFUMEY, L., CORRADETTI, R., LAPORTE, A.M., GOZLAN, H., HAMON, M. & DOURISH, C.T. (1996). Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY 100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav. Brain Res., 73, 337353.
  • GASTER, L.M., BLANEY, F.E., DAVIES, S., DUCKWORTH, D.M., HAM, P., JENKINS, S., JENNINGS, A.J., JOINER, G.F., KING, F.D., MULHOLLAND, K.R., WYMAN, P.A., HAGAN, J.J., HATCHER, J., JONES, B.J., MIDDLEMISS, D.N., PRICE, G.W., RILEY, G., ROBERTS, C., ROUTLEDGE, C., SELKIRK, J. & SLADE, P.D. (1998). The selective 5-HT1B receptor inverse agonist 1′-methyl-5[[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl-2,3,6,7-tetrahydrospiro[furo[2,3-F]indole-3,4′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. J. Med. Chem., 41, 12181235.
  • HIRST, W.D., MINTON, J.A.L., BROMIDGE, S.M., MOSS, S.F., LATTER, A.J., RILEY, G., ROUTLEDGE, C., MIDDLEMISS, D.N. & PRICE, G.W.Characterisation of[125I]SB-258585binding to human recombinant and native5-HT receptors in rat, pig and human brain tissue. Br. J. Pharmacol., (in press).
  • KIMBALL, A.W., BURNETT, W.T. & DOHERTY, D.G. (1957). Chemical protection against ionising radiation I. Sampling methods of screening compounds in radiation protection studies in mice. Radiation Res., 7, 112.
  • KOHEN, R., METCALF, M.A., KHAN, N., DRUCK, T., HEUBNER, K., LACHOWICZ, J.E., MELTZER, H.Y., SIBLEY, D.R., ROTH, B.L. & HAMBLIN, M.W. (1996). Cloning, characterisation, and chromosomal localisation of a human 5-HT6 serotonin receptor. J. Neurochem., 66, 4756.
  • LITCHFIELD, J.T. & WILCOXON, F. (1949). A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther., 96, 99113.
  • MONSMA, JR. F.J., SHEN, Y., WARD, R.P., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol., 43, 320327.
  • ROGERS, D.C., ROBINSON, T.L., QUILTER, C.A., HUNTER, A.J., ROUTLEDGE, C. & HAGAN, J.J. (1999). Cognitive enhancement effects of the selective 5-HT6 antagonist SB-271046. Br. J. Pharmacol., 127, 22P.
  • ROTH, B.L., CRAIGO, S.C., CHOUDHARY, M.S., ULUER, A., MONSMA, F.J., SHEN, Y., MELTZER, H.Y. & SIBLEY, D.R. (1994). Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther., 268, 14031410.
  • ROUTLEDGE, C, PRICE, G.W., BROMIDGE, S.M., MOSS, S.F., NEWMAN, H., RILEY, G., GAGER, T., BROWN, A.M., LIGHTOWLER, S. & MIDDLEMISS, D.N. (1999). Characterisation of SB-271046, a potent and selective 5-HT6 receptor antagonist. Br. J. Pharmacol., 127, 21P.
  • RUAT, M., TRAIFFORT, E., ARRANG, J.M., TARDIVEL-LACOMBE, J., DIAZ, J., LEURS, R. & SCHWARTZ, J.C. (1993). A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem. Biophys. Res. Comm., 193, 268276.
  • SALOMON, Y. (1979). Adenylate cyclase assay. Adv. Cyclic. Nuc. Res., 10, 3555.
  • SCHOEFFTER, P. & WAEBER, C. (1994). 5-Hydroxytryptamine receptors with a 5-HT6 receptor-like profile stimulating adenylyl cyclase activity in pig caudate membranes. Naunyn Schmiedebergs Arch. Pharmacol., 350, 356360.
  • SLEIGHT, A.J., BOESS, F.G., BOS, M., LEVET-TRAFIT, B., RIEMER, C. & BOURSON, A. (1998). Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors. Br. J. Pharmacol., 124, 556562.
  • STEAN, T., ROUTLEDGE, C. & UPTON, N. (1999). Anticonvulsant properties of the selective 5-HT6 receptor antagonist SB-271046-A in the rat maximal electroshock seizure threshold test. Br. J. Pharmacol., 127, 131P.
  • UPTON, N., BLACKBURN, T.P., CAMPBELL, C.A., COOPER, D., EVANS, M.L., HERDON, H.J., KING, P.D., RAY, A.M., STEAN, T.O., CHAN, W.N., EVANS, J.M. & THOMPSON, M. (1997). Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalised epileptic seizures. Br. J. Pharmacol., 121, 16791686.
  • UPTON, N., STEAN, T.O. & BLACKBURN, T.P. (1993). BRL 46470A, a selective 5-HT3 receptor antagonist, attenuates the increased seizure susceptibility observed during diazepam-induced withdrawal in mice. Br. J. Pharmacol., 108, 254P.
  • UPTON, N., STEAN, T.O., MIDDLEMISS, D., BLACKBURN, T. & KENNETT, G. (1998). Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents. Eur. J. Pharmacol., 359, 3340.
  • YAU, J.L.W., NOBLE, J., WIDDOWSON, J. & SECKL, J.R. (1997). Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus. Mol. Brain Res., 45, 182186.
  • YOSHIOKA, M., MATSUMOTO, M., TOGASHI, H., MORI, K. & SAITO, H. (1998). Central distribution and function of 5-HT6 receptor subtype in the rat brain. Life Sci., 62, 14731477.